UBS Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-818
| Closed | -$2.18K | – | 9095 |
|
|
2024
Q1 | $2.18K | Sell |
818
-4,273
| -84% | -$11.4K | ﹤0.01% | 6793 |
|
|
2023
Q4 | $12.1K | Buy |
+5,091
| New | +$12.1K | ﹤0.01% | 6160 |
|
|
2021
Q4 | – | Sell |
-730
| Closed | -$17K | – | 9562 |
|
|
2021
Q3 | $17K | Buy |
730
+478
| +190% | +$11.1K | ﹤0.01% | 6227 |
|
|
2021
Q2 | $6K | Sell |
252
-536
| -68% | -$12.8K | ﹤0.01% | 7368 |
|
|
2021
Q1 | $25K | Sell |
788
-39,165
| -98% | -$1.24M | ﹤0.01% | 6168 |
|
|
2020
Q4 | $1.59M | Buy |
+39,953
| New | +$1.59M | ﹤0.01% | 2799 |
|